Albemarle Investor Presentation

Adjusted EBITDA supplemental¹ ($ in thousands) Adjusted EBITDA Net income attributable to noncontrolling interests Equity in net income of unconsolidated investments (net of tax) Dividends received from unconsolidated investments Consolidated EBITDA Total Long Term Debt (as reported) Off balance sheet obligations and other Consolidated Funded Debt Less Cash Consolidated Funded Net Debt Twelve Months Ended Mar 31, 2023 Mar 31, 2023 Three Months Ended Dec 31, 2022 Sep 30, 2022 4,639,646 $ 1,595,719 $ 1,243,752 $ 1,189,966 $ 135,274 38,123 29,341 33,991 (1,106,027) (396,188) (322,799) (258,884) Jun 30, 2022 610,209 33,819 (128,156) 1,309,623 547,552 450,344 193,931 $ 4,978,516 $ 1,785,206 $ 1,400,638 $ 1,159,004 $ 117,796 633,668 $ 3,235,560 146,200 $ 3,381,760 1,586,734 $ 1,795,026 0.7 0.4 Consolidated Funded Debt to Consolidated EBITDA Ratio Consolidated Funded Net Debt to Consolidated EBITDA Ratio 1 This supplemental is for net-debt-to-adjusted EBITDA ratio based on the bank covenant definition. ALBEMARLE 39 99

View entire presentation